Hb target achievement and associated predictors of roxadustat therapy across baseline anemia severities in maintenance hemodialysis: A single-center real-world retrospective cohort study

作者
Jiao Yuan,Yingsong Jiang
出处
期刊:Clinical Nephrology [Dustri-Verlag]
卷期号:106 (2): 119-136
标识
DOI:10.5414/cn111997
摘要

BACKGROUND: Anemia is common in maintenance hemodialysis (MHD). Therapy with erythropoiesis-stimulating agents (ESAs) may be limited by inflammation-related hyporesponsiveness and safety concerns. Real-world evidence on roxadustat across baseline anemia severities is limited. MATERIALS AND METHODS: In this single-center retrospective cohort, 300 MHD patients who switched from ESAs to roxadustat monotherapy were grouped by baseline hemoglobin (Hb): severe < 80 g/L (n = 82), moderate 80 - 99 g/L (n = 137), and mild 100 - 110 g/L (n = 81). The primary outcome was sustained Hb target achievement (100 - 120 g/L for ≥ 2 consecutive visits within 12 weeks without rescue therapy). Hb trajectories were assessed using linear mixed-effects models, and predictors of target achievement were identified by multivariable logistic regression with false discovery rate adjustment. RESULTS: At 12 weeks, sustained Hb achievement increased with baseline Hb: 46.3% (severe), 64.2% (moderate), and 76.5% (mild) (q = 0.0012). Hb variability decreased across groups (time-weighted coefficients of variation 7.5, 6.1, and 5.2%; q = 0.008). Early Hb rise was fastest in severe anemia (+1.85 vs. +1.24 vs. +0.74 g/L/week over weeks 0 - 4; q = 0.028). Adverse events occurred in 47.7%, mostly grade 1 - 2, without between-group differences in serious events or discontinuation. Higher C-reactive protein (per 10 mg/L, OR 0.42; q = 0.012) and poor prior ESA response (OR 0.60; q = 0.013) predicted lower target attainment, whereas higher prealbumin (per 10 mg/L, OR 1.35; q = 0.004), IV iron (OR 1.52; q = 0.021), and ≥ 50% dose titration (OR 1.59; q = 0.019) predicted higher attainment. CONCLUSION: Roxadustat improved and stabilized Hb across anemia severities in MHD, with best control in milder anemia; inflammation, nutrition, prior ESA response, iron use, and dose titration influenced success.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ding的应助被cen采纳,获得10
刚刚
濮阳冰海完成签到 ,获得积分10
刚刚
1秒前
1秒前
ailisi关注了科研通微信公众号
1秒前
1秒前
guojianfang完成签到,获得积分10
1秒前
鲸鱼完成签到 ,获得积分10
2秒前
Wuwj完成签到 ,获得积分10
2秒前
土豆泥完成签到,获得积分10
3秒前
新手完成签到,获得积分10
3秒前
4秒前
苹果牌牛仔裤完成签到,获得积分10
5秒前
清脆的代芹的应助被nzx采纳,获得50
5秒前
Hello的应助被粗暴的巧凡采纳,获得30
5秒前
zhz发布了新的文献求助10
5秒前
lilian发布了新的文献求助10
5秒前
5秒前
6秒前
7秒前
听安完成签到 ,获得积分10
7秒前
素素素发布了新的文献求助10
7秒前
8秒前
shadyislighter的应助被kanghuihui采纳,获得10
8秒前
9秒前
9秒前
9秒前
9秒前
Jamelin12发布了新的文献求助30
11秒前
共享精神的应助被埃芬博格采纳,获得10
12秒前
12秒前
阳春发布了新的文献求助10
12秒前
12秒前
其7完成签到,获得积分10
13秒前
科研通AI6.4的应助被乐正如彤采纳,获得10
13秒前
迷路曼凝完成签到 ,获得积分10
13秒前
等天晴发布了新的文献求助10
13秒前
科研通AI2S的应助被小薛采纳,获得10
13秒前
张正友完成签到 ,获得积分10
14秒前
hhcc发布了新的文献求助20
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Spec 401: Standards for Jet Fuel Facility and Equipment Commissioning and Flushing at Airports, 2026.1 (Original Issue) 1000
Spec 103: Standard for Jet Fuel Quality Control at Airports, Revision 2026.1 1000
Mathematical models in hydrology 1000
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Introduction to Industrial/Organizational Psychology 800
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8092907
求助须知:如何正确求助?哪些是违规求助? 9505162
关于积分的说明 21445927
捐赠科研通 7665928
什么是DOI,文献DOI怎么找? 3405399
关于科研通互助平台的介绍 2533716
邀请新用户注册赠送积分活动 2444528